MFX
PrivateLast Round
Grant
Nov 19, 2025
Total Funding Raised
$2.61M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MFX is a biotechnology company that provides a scalable bioreactor and data platform for cell and gene therapy research, development, and manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MFX Comparables
Compare MFX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ori Biotech | 88% | |
| Aglaris | 87% | |
| Adva Biotechnology | 87% | |
MFX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 19, 2025 | ||||
| Grant | Dec 19, 2023 | ||||
| VC Round | Dec 8, 2022 | ||||
| Seed | Apr 20, 2020 |
MFX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Cambridge Angels | Seed |
| UK Innovation & Science Seed Fund | VC Round, Seed |
| Perscitus LLP | VC Round |
| 88 Capital & Investments | Seed |
| Puffin Point | VC Round |
| Longwall Venture Partners | VC Round, Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 19, 2025
Received grant funding.
- Mar 17, 2025
Dr. Katy Newton appointed to lead innovation in cell-based therapies.
MFX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MFX's valuation, stock price, and market status.